Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.09M | -38.84M | -34.17M | -32.79M | -25.83M |
| Total Depreciation and Amortization | 2.66M | 2.33M | 1.98M | 2.37M | 2.03M |
| Total Amortization of Deferred Charges | 408.00K | 468.00K | 469.00K | 468.00K | 469.00K |
| Total Other Non-Cash Items | 16.22M | 12.39M | 11.23M | 10.89M | 3.04M |
| Change in Net Operating Assets | -7.50M | 4.93M | 2.12M | 711.00K | -5.98M |
| Cash from Operations | -32.30M | -18.72M | -18.37M | -18.34M | -26.27M |
| Capital Expenditure | -8.34M | -9.67M | -9.99M | -7.50M | -8.27M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.02M | -163.04M | -4.93M | 80.00K | 37.00K |
| Cash from Investing | -21.35M | -172.71M | -14.92M | -7.42M | -8.23M |
| Total Debt Issued | 75.00M | -- | -- | -- | -- |
| Total Debt Repaid | -50.15M | -- | -- | -- | -- |
| Issuance of Common Stock | 2.44M | 593.00K | 149.29M | -- | -- |
| Repurchase of Common Stock | -1.01M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.78M | -778.00K | -109.00K | -27.00K | -1.88M |
| Cash from Financing | 22.50M | -185.00K | 149.18M | -27.00K | -1.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.15M | -191.61M | 115.90M | -25.79M | -36.38M |